CADD522
CADD522 (MFCD00167693) is a potent small molecule inhibitor that disrupts RUNX2-DNA binding with an IC50 of 10 nM. It exhibits antitumor activity and is a valuable research tool for studying RUNX2 function in cancer biology, bone metastasis, and osteosarcoma in both cellular and animal models.
Product Specifications
CAS Number
199735-88-1
Product Name Alternative
Reactive Oxygen Species, T47D-RUNX2, runt-related transcription factor-2 (RUNX2) -DNA, inhibit, MFCD00167693, MFCD-00167693, MFCD 00167693, Inhibitor, MDA-231, MDA-468, MCF7, CADD 522, CADD522, CADD-522, breast cancer
Field of Research
Immunology & Inflammation, Metabolism Research, Signal Transduction
Purity
95.81% (May vary between batches)
Solubility
DMSO:245 mg/mL (751.14 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (15.33 mM)
Smiles
OC (=O) C1C2CC (C=C2) C1C (=O) NC1=CC=C (Cl) C (Cl) =C1
Molecular Formula
C15H13Cl2NO3
Molecular Weight
326.17
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC682362-500 1x 500 µL
GAD2 / GAD65 (GABAergic Neuronal Marker) (GAD2/2362), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
RDR-AGE-Ge-01 96 Tests
General Advanced Glycation End Product (AGE) ELISA Kit
Sign In for Pricing
View Details